Jarron Lincoln
Family Medicine · Shelbyville, INNPI 1255685772
Payments from drug & device makers
Across 124 payments — averaging $18.03 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$371
- Supernus Pharmaceuticals, Inc.$324
- Novo Nordisk$200
- Pfizer$139
- Boehringer Ingelheim$133
- Amgen$130
- plus $938 from 27 others
What the payments were for
- Food & beverage$2,235100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 21 | $371 |
| Supernus Pharmaceuticals, Inc. | 5 | $324 |
| Novo Nordisk | 14 | $200 |
| Pfizer | 10 | $139 |
| Boehringer Ingelheim | 9 | $133 |
| Amgen | 9 | $130 |
| Novartis | 7 | $120 |
| Lilly USA, LLC | 5 | $82 |
| Axsome Therapeutics, Inc. | 4 | $65 |
| GSK | 4 | $63 |
| Otsuka America Pharmaceutical, Inc. | 3 | $59 |
| Biohaven Pharmaceutical Holding Company Ltd. | 4 | $55 |
| Dynavax Technologies Corporation | 2 | $49 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 3 | $47 |
| Biohaven Pharmaceuticals, Inc. | 2 | $38 |
| AstraZeneca | 2 | $34 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $34 |
| Medtronic | 1 | $32 |
| Exact Sciences | 2 | $29 |
| Merck | 2 | $26 |
| Corcept Therapeutics | 1 | $24 |
| Regeneron Healthcare Solutions, Inc. | 1 | $24 |
| Amarin Pharma, Inc. | 1 | $17 |
| Astellas Pharma US Inc | 1 | $17 |
| Paratek Pharmaceuticals, Inc. | 1 | $16 |
| Mylan Specialty L.p. | 1 | $15 |
| Sanofi Pasteur Inc. | 1 | $14 |
| Sanofi-aventis U.S. LLC | 1 | $14 |
| Antares Pharma, Inc. | 1 | $14 |
| IBSA Pharma Inc. | 1 | $13 |
| Corium, LLC | 1 | $13 |
| Gilead | 1 | $12 |
| Johnson & Johnson | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- QELBREE$143
How this compares
$2,235 in reported general payments places this provider in the 70th percentile of 2,709 family medicine providers in Indiana.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 99 | $143,098 |
| JardianceEmpagliflozin | 69 | $85,941 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 98 | $72,474 |
| FarxigaDapagliflozin Propanediol | 50 | $61,747 |
| EliquisApixaban | 54 | $43,286 |
| RybelsusSemaglutide | 19 | $42,319 |
| MounjaroTirzepatide | 33 | $38,115 |
| TrulicityDulaglutide | 22 | $28,831 |
| ArexvyRsvpref3 Antigen/As01e/Pf | 72 | $22,357 |
| Breo ElliptaFluticasone/Vilanterol | 25 | $17,516 |
| MyrbetriqMirabegron | 18 | $14,177 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 22 | $13,823 |
| ShingrixVaricella-Zoster Ge/As01b/Pf | 56 | $12,176 |
| Spiriva RespimatTiotropium Bromide | 11 | $5,707 |
| Stiolto RespimatTiotropium Br/Olodaterol Hcl | 11 | $5,166 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic, Rybelsus | $200 | $185,417118 claims |
| GSKTrelegy Ellipta, Arexvy, Breo Ellipta, Shingrix | $63 | $124,522251 claims |
| Boehringer IngelheimJardiance, Spiriva Respimat, Stiolto Respimat | $133 | $96,81491 claims |
| AstraZenecaFarxiga, Breztri Aerosphere | $34 | $75,57072 claims |
| Lilly USA, LLCMounjaro, Trulicity | $82 | $66,94655 claims |
| PfizerEliquis | $139 | $43,28654 claims |
| Astellas Pharma US IncMyrbetriq | $17 | $14,17718 claims |
| AbbVieArmour Thyroid | $371 | $1,10712 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 2,709 family medicine providers in Indiana.
Other family medicine in Shelbyville
- Blair BrengleIndianapolis$10.6M
- Laura HelmanMishawaka$4M
- J Christopher SartoreEvansville$3.9M
- Hubert ReyesEvansville$3.2M
- David SchultzEvansville$3M
- Steven SmithIndianapolis$2.5M
- Renee Michelle GalenNewburgh$2.1M
- Eric HewittAvon$1.7M
- Alexander Dela LlanaEvansville$1.6M
- Jonathan ConditMuncie$1.6M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.